Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 338 dokumen yang sesuai dengan query
cover
Lancaster: Pennsylvania Technomic , 1997
620.82 BIO
Buku Teks SO  Universitas Indonesia Library
cover
Curran, Mary Ann
New York: McGraw-Hill, 1996
620.82 CUR e
Buku Teks SO  Universitas Indonesia Library
cover
Jakarta: AIPI, 1999
620.82 IND p
Buku Teks SO  Universitas Indonesia Library
cover
Prentis, Steve
Jakarta: Erlangga, 1991
620.82 PRE b
Buku Teks SO  Universitas Indonesia Library
cover
Rittman, Bruce E.
Boston: McGrow-Hill , 2001
660.6 RIT e
Buku Teks SO  Universitas Indonesia Library
cover
Robbins-Roth, Cynthia
Cambridge, UK: Perseus Publishing , 2000
660.6 ROB f
Buku Teks SO  Universitas Indonesia Library
cover
"Berita tentang masih perlunya impor beras,adanya konsep raskin operasi pasar,dijumpainya anak-anak kurang gizi dan kejadian keracunan makanan pada sekelompok orang setelah mendapat pembagian makanan atau hidangan di berbagai daerah di tanah air merupakan bukti adanya hal yang kurang beres dalam masalah pangan
"
Artikel Jurnal  Universitas Indonesia Library
cover
Seidman, Lisa A.
San Francisco: Pearson Benjamin Cummings, 2008
660.6 SEI b
Buku Teks SO  Universitas Indonesia Library
cover
"The sequencing of the human genome opened a new world of biomarkers. Is it possible to tell by a person's genetic signature how they would respond to a particular drug? his is the dream of "personalized medicine". At the moment as many as half of all drugs do not work for the people who take them. Such pharmacogenomics could also reduce the size and cost of clinical tests by allowing pharma firms to select the most suitable patients. But the reality is rather different. The difficulty lies in proving that they reliably correlete with clinical outcome. Companies that had placed their faith in genomics are now caught in a dilemma: to produce information only or new drugs. As the cost of gene sequencing has fallen, firms have rushed to offer genetic tests directly to consumers, often raising grand expectations. There now seems to be a backlash. Doctors have complained about being bypassed. Most generic tests directly do not provide conclusive evidence of this risk of disease Some academics also remain deeply skeptical about genomics being used in medicine. In addition , personalised medicine would be economic folly for firms who would need to develop a special pill for every patient. Traditionally firms sold conventional one - size - all drugs. Perhaps a better way would be mass customization."
Artikel Jurnal  Universitas Indonesia Library
cover
Sobti, R.C.
Boca Raton: CRC Press, Taylor & Francis Group, 2009
660.6 SOB e
Buku Teks SO  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>